Biotech Pioneer SQIM from Italy secures €11M in Series A Funding
In a significant development for the biotech industry, SQIM (formerly known as Mogu Srl), an Italian company at the forefront of material innovation, has successfully secured €11 million in a Series A funding round. This substantial investment, led by CDP Venture Capital, marks a pivotal moment in the company's journey towards revolutionizing the use of mycelium-based materials.
In a significant development for the biotech industry, SQIM (formerly known as Mogu Srl), an Italian company at the forefront of material innovation, has successfully secured €11 million in a Series A funding round. This substantial investment, led by CDP Venture Capital, marks a pivotal moment in the company's journey
Matisse Pharmaceuticals, a clinical-stage company based in Geelan, the Netherlands, has announced securing €3.6M in a fresh funding round. This investment, contributed by Brightlands Venture Partners, private investment companies, informal investors, and the management team, will support Matisse in its preparation for a large-scale phase II study in sepsis patients.

The best Articles in our Network

Previous
Next